Dual inhibition of butyrylcholinesterase and p38α mitogen-activated protein kinase : a new approach for the treatment of Alzheimer's disease

Ferjančič Benetik, Svit (avtor), Knez, Damijan (avtor), Obreza, Aleš (avtor), Košak, Urban (avtor), Gobec, Stanislav (avtor)

The simultaneous targeting of neuroinflammation and cholinergic hypofunction, the key pathological changes in Alzheimer's disease (AD), is not addressed by drugs currently in clinical trials, highlighting a critical therapeutic gap. We propose that dual-acting small molecules that inhibit butyrylcholinesterase (BChE) and mitogen-activated protein kinase p38α (p38α MAPK) represent a novel strategy to combat AD. This hypothesis is supported by cellular and animal studies as well as in silico modelling showing that it is possible to act simultaneously on both enzymes. Amyloid beta (Aβ) plaques trigger a pro-inflammatory microglial response that overactivates p38α MAPK, leading to increased Aβ synthesis, tau hyperphosphorylation, and altered synaptic plasticity. Overactivated microglia exacerbate neuroinflammation and cholinergic degeneration, ultimately leading to cognitive impairment. Structural similarities between the binding sites of BChE and p38α MAPK provide a promising basis for the development of dual inhibitors that could alleviate AD symptoms and address the underlying pathology.

• Jezik: Angleški jezik
• Ključne besede: Alzheimer's disease, neuroinflammation, butyrylcholinesterase, p38α mitogen-activated protein kinase, neurodegeneration, selectivity
• Vrsta gradiva: Članek v reviji
• Tipologija: 1.02 - Pregledni znanstveni članek
• Organizacija: FFA - Fakulteta za farmacijo
• Status publikacije: Objavljeno
• Različica publikacije: Objavljena publikacija
• Leto izida: 2024
• Št. strani: 13 str.
• Številčenje: Vol. 264, art. 108748
• PID: 20.500.12556/RUL-164882
• UDK: 616.894
• ISSN pri članku: 0163-7258
• DOI: 10.1016/j.pharmthera.2024.108748
• COBISS.SI-ID: 215038723
• Datum objave v RUL: 15.11.2024

Gradivo je del revije

• Naslov: Pharmacology & therapeutics
• Skrajšan naslov: Pharmacol. ther.
• Založnik: Elsevier
• ISSN: 0163-7258
• COBISS.SI-ID: 26118144

Licence

• Licenca: CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
• Povezava: http://creativecommons.org/licenses/by/4.0/deed.sl
• Opis: To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

• Jezik: Slovenski jezik
• Ključne besede: Alzheimerjeva bolezen, nevrovnetje, butirilholinesteraza, p38α mitogen aktivirana protein kinaza, nevrodegeneracija, nevrodegenerativne bolezni